Please login to the form below

Not currently logged in
Email:
Password:

Publicis appoints Kipp Jarecke-Cheng as global comms chief

He joins the network from US digital design agency FOUR32C

Publicis Healthcare Communications Group (PHCG) Kipp Jarecke-ChengKipp Jarecke-Cheng has joined Publicis Healthcare Communications Group (PHCG) as global chief communications officer.

He moves to the network from US digital design agency FOUR32C, where he served as its director of marketing.

Prior to that he was director of global public relations and communications at Nurun, a digital design consultancy acquired by Publicis in 2014.

Jarecke-Cheng said: "Health communications is rooted in collaboration to create purpose-driven behaviour change. I am thrilled to join PHCG, one of the organizations at the forefront of health innovation and creativity that every day delivers meaningful solutions for its clients.”

In his new role Jarecke-Cheng will lead communications across the network's 15 agencies, which include Digitas Health LifeBrands, Langland and Publicis Health Media. He will report to PHCG's chief executive Nick Colucci and sit on the network's executive and operations committees.

Colucci said: "Kipp's diverse background in human-centered design, digital platforms, and strategic communications is well aligned to the direction and future of the group. I am excited to have him join PHCG's executive management team."

16th May 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics